{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:50:42Z","timestamp":1790243442581,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T00:00:00Z","timestamp":1542240000000},"content-version":"am","delay-in-days":318,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["JP23107004"],"award-info":[{"award-number":["JP23107004"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["AS262Z01189Q"],"award-info":[{"award-number":["AS262Z01189Q"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005865","name":"Mochida Memorial Foundation for Medical and Pharmaceutical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007807","name":"Japan Science Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009029","name":"Adaptable and Seamless Technology Transfer Program through Target-Driven R and D","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009029","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP16H05910"],"award-info":[{"award-number":["JP16H05910"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP26750155"],"award-info":[{"award-number":["JP26750155"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.jconrel.2017.11.016","type":"journal-article","created":{"date-parts":[[2017,11,12]],"date-time":"2017-11-12T08:01:34Z","timestamp":1510473694000},"page":"148-158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"special_numbering":"C","title":["Polyrotaxane-based systemic delivery of \u03b2-cyclodextrins for potentiating therapeutic efficacy in a mouse model of Niemann-Pick type C disease"],"prefix":"10.1016","volume":"269","author":[{"given":"Atsushi","family":"Tamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5212-1371","authenticated-orcid":false,"given":"Nobuhiko","family":"Yui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2017.11.016_bb0005","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1084\/jem.20121239","article-title":"Neuroprotection by cyclodextrin in cell and mouse models of Alzheimer disease","volume":"209","author":"Yao","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2017.11.016_bb0010","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1073\/pnas.0810895106","article-title":"Reversal of defective lysosomal transport in NPC disease ameliorates liver dysfunction and neurodegeneration in the npc1\u2013\/\u2013 mouse","volume":"106","author":"Liu","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2017.11.016_bb0015","first-page":"E1402","article-title":"Beta cyclodextrins bind, stabilize, and remove lipofuscin bisretinoids from retinal pigment epithelium","author":"Nociari","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2017.11.016_bb0020","doi-asserted-by":"crossref","first-page":"333ra50","DOI":"10.1126\/scitranslmed.aad6100","article-title":"Cyclodextrin promotes atherosclerosis regression via macrophage reprogramming","volume":"8","author":"Zimmer","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2017.11.016_bb0025","doi-asserted-by":"crossref","first-page":"17250","DOI":"10.1074\/jbc.270.29.17250","article-title":"Cellular cholesterol efflux mediated by cyclodextrins","volume":"270","author":"Kilsdonk","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2017.11.016_bb0030","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1248\/bpb.32.700","article-title":"Involvement of lipid rafts of rabbit red blood cells in morphological changes induced by methylated \u03b2-cyclodextrins","volume":"32","author":"Motoyama","year":"2009","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jconrel.2017.11.016_bb0035","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1750-1172-5-16","article-title":"Niemann-pick disease type C","volume":"5","author":"Vanier","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.jconrel.2017.11.016_bb0040","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1126\/science.277.5323.228","article-title":"Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis","volume":"277","author":"Carstea","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2017.11.016_bb0045","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1126\/science.290.5500.2298","article-title":"Identification of HE1 as the second gene of Niemann-pick C disease","volume":"290","author":"Naurechiene","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2017.11.016_bb0050","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1471-4159.2010.06976.x","article-title":"Niemann-pick type C disease: molecular mechanisms and potential therapeutic approaches","volume":"116","author":"Rosenbaum","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jconrel.2017.11.016_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006951","article-title":"Chronic cyclodextrin treatment of murine Niemann-pick C disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression","volume":"4","author":"Davidson","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2017.11.016_bb0060","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1194\/jlr.M000257","article-title":"Cyclodextrin overcomes the transport defect in nearly every organ of NPC1 mice leading to excretion of sequestered cholesterol as bile acid","volume":"51","author":"Liu","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jconrel.2017.11.016_bb0065","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1194\/jlr.M013789","article-title":"Quantitative role of LAL, NPC2, and NPC1 in lysosomal cholesterol processing defined by genetic and pharmacological manipulations","volume":"52","author":"Ramirez","year":"2011","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jconrel.2017.11.016_bb0070","doi-asserted-by":"crossref","first-page":"276ra26","DOI":"10.1126\/scitranslmed.3010101","article-title":"Intracisternal cyclodextrin prevents cerebellar dysfunction and Purkinje cell death in feline Niemann-Pick type C1 disease","volume":"7","author":"Vite","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2017.11.016_bb0075","doi-asserted-by":"crossref","first-page":"19316","DOI":"10.1073\/pnas.0910916106","article-title":"Cyclodextrin overcomes deficient lysosome-to-endoplasmic reticulum transport of cholesterol in Niemann-pick type C cells","volume":"106","author":"Abi-Mosleh","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2017.11.016_bb0080","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ymgme.2012.11.005","article-title":"Effects of cyclodextrin in two patients with Niemann\u2013pick type C disease","volume":"108","author":"Matsuo","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.jconrel.2017.11.016_bb0085","first-page":"391","article-title":"Effects of intracerebroventricular administration of 2-hydroxypropyl-\u03b2-cyclodextrin in a patient with Niemann\u2013pick type C disease","volume":"1","author":"Matsuo","year":"2014","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.jconrel.2017.11.016_bb0090","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ymgme.2015.07.001","article-title":"Intrathecal 2-hydroxypropyl-beta-cyclodextrin in a single patient with Niemann-pick C1","volume":"116","author":"Maarup","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.jconrel.2017.11.016_bb0095","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/S0140-6736(17)31465-4","article-title":"Intrathecal 2-hydroxypropyl-\u03b2-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1\u20132 trial","volume":"390","author":"Ory","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2017.11.016_bb0100","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.fct.2005.03.007","article-title":"2-Hydroxypropyl-\u03b2-cyclodextrin (HP-\u03b2-CD): a toxicology review","volume":"43","author":"Gould","year":"2005","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.jconrel.2017.11.016_bb0105","first-page":"19","article-title":"Influence of Npc1 genotype on the toxicity of hydroxypropyl-\u03b2-cyclodextrin, a potentially therapeutic agent, in Niemann-pick type C disease models","volume":"1","author":"Tanaka","year":"2014","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.jconrel.2017.11.016_bb0110","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ymgme.2013.04.003","article-title":"Lung toxicity of hydroxypropyl-\u03b2-cyclodextrin infusion","volume":"109","author":"Chien","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.jconrel.2017.11.016_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053280","article-title":"Hearing loss and hair cell death in mice given the cholesterol-chelating agent hydroxypropyl-\u03b2-cyclodextrin","volume":"7","author":"Crumling","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2017.11.016_bb0120","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/1521-4141(200003)30:3<954::AID-IMMU954>3.0.CO;2-Y","article-title":"Cholesterol depletion disrupts lipid rafts and modulates the activity of multiple signaling pathways in T lymphocytes","volume":"30","author":"Kabouridis","year":"2000","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jconrel.2017.11.016_bb0125","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/356325a0","article-title":"The molecular necklace: a rotaxane containing many threaded \u03b1-cyclodextrins","volume":"356","author":"Harada","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2017.11.016_bb0130","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.progpolymsci.2005.07.003","article-title":"Polypseudorotaxanes and polyrotaxanes","volume":"30","author":"Huang","year":"2005","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.jconrel.2017.11.016_bb0135","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1021\/cr970027+","article-title":"Cyclodextrin rotaxanes and polyrotaxanes","volume":"106","author":"Wenz","year":"2006","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2017.11.016_bb0140","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.addr.2008.02.011","article-title":"Cyclodextrin-based supramolecular architectures: syntheses, structures, and applications for drug and gene delivery","volume":"60","author":"Li","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2017.11.016_bb0145","doi-asserted-by":"crossref","first-page":"13433","DOI":"10.1039\/C4CC03709J","article-title":"Threaded macromolecules as a versatile framework for biomaterials","volume":"50","author":"Tamura","year":"2014","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jconrel.2017.11.016_bb0150","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.1038\/srep04356","article-title":"Lysosomal-specific cholesterol reduction by biocleavable polyrotaxanes for ameliorating Niemann-pick type C disease","volume":"4","author":"Tamura","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2017.11.016_bb0155","doi-asserted-by":"crossref","first-page":"9442","DOI":"10.1074\/jbc.M115.636803","article-title":"\u03b2-Cyclodextrin-threaded biocleavable polyrotaxanes ameliorate impaired autophagic flux in Niemann-Pick type C disease","volume":"290","author":"Tamura","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2017.11.016_bb0160","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1080\/14686996.2016.1200948","article-title":"Lysosomal pH-inducible supramolecular dissociation of polyrotaxanes possessing N-triphenylmethyl end groups and their therapeutic potential to Niemann-pick type C disease","volume":"17","author":"Tamura","year":"2016","journal-title":"Sci. Technol. Adv. Mater."},{"key":"10.1016\/j.jconrel.2017.11.016_bb0165","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1126\/science.277.5323.232","article-title":"Murine model of Niemann-pick C disease: mutation in a cholesterol homeostasis gene","volume":"277","author":"Loftus","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2017.11.016_bb0170","first-page":"1787","article-title":"A simple composite phenotype scoring system for evaluating mouse models of cerebellar ataxia","volume":"39","author":"Guyenet","year":"2010","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.jconrel.2017.11.016_bb0175","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0002-9440(10)63953-3","article-title":"Fas (CD95) induces alveolar epithelial cell apoptosis in vivo: implications for acute pulmonary inflammation","volume":"158","author":"Matute-Bello","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jconrel.2017.11.016_bb0180","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1139\/y59-099","article-title":"A rapid method of total lipid extraction and purification","volume":"37","author":"Bligh","year":"1959","journal-title":"Can. J. Biochem. Physiol."},{"key":"10.1016\/j.jconrel.2017.11.016_bb0185","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001417","article-title":"Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-pick C1 disease","volume":"2","author":"Porter","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2017.11.016_bb0190","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1194\/jlr.D040790","article-title":"High-temperature GC-MS-based serum cholesterol signatures may reveal sex differences in vasospastic angina","volume":"55","author":"Son","year":"2014","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jconrel.2017.11.016_bb0195","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1248\/bpb.b14-00726","article-title":"Efficacy of 2-hydroxypropyl-\u03b2-cyclodextrin in Niemann-pick disease type C model mice and its pharmacokinetic analysis in a patient with the disease","volume":"38","author":"Tanaka","year":"2015","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jconrel.2017.11.016_bb0200","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/hmg\/ddp552","article-title":"Conditional Niemann-Pick C mice demonstrate cell autonomous Purkinje cell neurodegeneration","volume":"19","author":"Elrick","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jconrel.2017.11.016_bb0205","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1093\/hmg\/11.24.3107","article-title":"Rescue of neurodegeneration in Niemann-pick C mice by a prion-promoter-driven Npc1 cDNA transgene","volume":"11","author":"Loftus","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jconrel.2017.11.016_bb0210","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1203\/PDR.0b013e3181ee4dd2","article-title":"Weekly cyclodextrin administration normalizes cholesterol metabolism in nearly every organ of the Niemann-pick type C1 mouse and markedly prolongs life","volume":"68","author":"Ramirez","year":"2010","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.jconrel.2017.11.016_bb0215","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nrm2336","article-title":"Cellular cholesterol trafficking and compartmentalization","volume":"9","author":"Ikonen","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jconrel.2017.11.016_bb0220","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00041433-200402000-00008","article-title":"Phytosterols and cholesterol metabolism","volume":"15","author":"Ostlund","year":"2004","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.jconrel.2017.11.016_bb0225","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/MOL.0000000000000038","article-title":"Cholesterol precursors: more than mere markers of biosynthesis","volume":"25","author":"Brown","year":"2015","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.jconrel.2017.11.016_bb0230","first-page":"2281","article-title":"Niemann-pick C1 protects against atherosclerosis in mice via regulation of macrophage intracellular cholesterol trafficking","volume":"118","author":"Zhang","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2017.11.016_bb0235","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1152\/physrev.2000.80.1.361","article-title":"Oxysterols: modulators of cholesterol metabolism and other processes","volume":"80","author":"Schroepfer","year":"2000","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jconrel.2017.11.016_bb0240","first-page":"76","article-title":"Oxysterols and their cellular effectors","volume":"2","author":"Olkkonen","year":"2012","journal-title":"Biomol. Ther."},{"key":"10.1016\/j.jconrel.2017.11.016_bb0245","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1023\/A:1015929720063","article-title":"The pharmacokinetics of \u03b2-cyclodextrin and hydroxypropyl-\u03b2-cyclodextrin in the rat","volume":"7","author":"Frijlink","year":"1990","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2017.11.016_bb0250","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1023\/A:1015880819328","article-title":"Effect of molecular weight on the lymphatic absorption of water-soluble compounds following subcutaneous administration","volume":"7","author":"Supersaxo","year":"1990","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2017.11.016_bb0255","doi-asserted-by":"crossref","first-page":"7272","DOI":"10.1002\/anie.201301397","article-title":"Synthesis of paclitaxel-conjugated \u03b2-cyclodextrin polyrotaxane and its antitumor activity","volume":"52","author":"Yu","year":"2013","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2017.11.016_bb0260","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.1039\/C5TB00627A","article-title":"One-pot synthesis of water-soluble, \u03b2-cyclodextrin-based polyrotaxanes in a homogeneous water system and its use in bio-applications","volume":"3","author":"Yu","year":"2015","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jconrel.2017.11.016_bb0265","doi-asserted-by":"crossref","first-page":"22272","DOI":"10.1021\/acsami.5b05393","article-title":"D. Gd3+-1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic-2-hydroxypropyl-\u03b2-cyclodextrin\/Pluronic polyrotaxane as a long circulating high relaxivity MRI contrast agent","volume":"7","author":"Zhou","year":"2015","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2017.11.016_bb0270","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1002\/jbm.820211106","article-title":"Effect of molecular weight (Mw) of N-(2-hydroxypropyl)methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal, and intravenous administration to rats","volume":"21","author":"Seymour","year":"1987","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.jconrel.2017.11.016_bb0275","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/jps.2600830432","article-title":"Distribution and tissue uptake of poly(ethylene glycol) with different molecular weights after intravenous administration to mice","volume":"83","author":"Yamaoka","year":"1994","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.11.016_bb0280","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2017.11.016_bb0285","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ymgme.2013.04.010","article-title":"Reply: lung toxicity of hydroxyl-\u03b2-cyclodextrin infusion","volume":"109","author":"Matsuo","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.jconrel.2017.11.016_bb0290","doi-asserted-by":"crossref","DOI":"10.1038\/srep46737","article-title":"Pluronic based \u03b2-cyclodextrin polyrotaxanes for treatment of Niemann-pick type C disease","volume":"7","author":"Collins","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2017.11.016_bb0295","doi-asserted-by":"crossref","first-page":"9404","DOI":"10.1523\/JNEUROSCI.1317-11.2011","article-title":"Unesterified cholesterol accumulation in late endosomes\/lysosomes causes neurodegeneration and is prevented by driving cholesterol export from this compartment","volume":"31","author":"Aqul","year":"2011","journal-title":"J. Neurosci."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836591731012X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836591731012X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:32:58Z","timestamp":1759159978000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016836591731012X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":59,"alternative-id":["S016836591731012X"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.11.016","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polyrotaxane-based systemic delivery of \u03b2-cyclodextrins for potentiating therapeutic efficacy in a mouse model of Niemann-Pick type C disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.11.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}